Apella Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Apella Capital's LLY Position: Q3 2026 in Review
Apella Capital increased its Eli Lilly (LLY) stake by 58% in Q3 2026, buying an estimated $2.95M and bringing the position to 6,774 shares worth $8.05M. The position accounts for 0.1% of the portfolio, ranked #142.
Apella Capital first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,387 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Apella Capital held 6,774 shares of Eli Lilly worth $8.05M as of Q3 2026.
- Apella Capital bought 2,498 Eli Lilly shares in Q3 2026, an estimated $2.95M.
- Eli Lilly made up 0.1% of Apella Capital's portfolio in Q3 2026, its #142 holding.
- Apella Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- 1,387 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.